Robo-advisors are changing the way people invest, and Morgan Stanley is getting in on the trend through the launch of its online investing platform Access Investing. Naureen Hassan, Chief Digital Officer at Morgan Stanley Wealth Management, joined Cheddar to discuss the investment trends among younger people that influenced the company's decision to offer Access Investing.
Morgan Stanley is trying to appeal to the younger generation of investors. To do so, the company is going head-to-head with robo-advisors such as Betterment and WealthFront. Hassan says that Morgan Stanley is differentiating its product through thematic investment portfolios. She explains that 42% of Access Investing accounts have thematic portfolios. The most popular theme is Robotics and Artificial Intelligence, which is used in about 19% of accounts.
Hassan emphasizes that the integration of technology into investing resonates with younger investors. She points out that 71% of accounts opened, were by people under the age of 45. As users financial needs become more complex, Morgan Stanley hopes to transition the clients into their traditional wealth advisory business.
Joby CPO Eric Allison discusses the UAE’s historic EVTOL take off, marking Dubai as the launchpad for global air taxi adoption and Joby’s commercial readiness.
CFRA’s Angelo Zino joins us to unpack Meta’s Superintelligence Labs and what it means for the future of AI, innovation, and the company’s bold new direction.
AIRO CEO Joe Burns and Executive Chairman Chirinjeev Kathuria talks the future of aerospace, drones, and urban air mobility through innovation and synergy.
NYC's mayoral race heats up with a socialist candidate aiming to make the city affordable—and rattling the financial sector. Plus: Coinbase's prospects.
Mark Hamrick of Bankrate discusses the jobs market, AI's growing impact on employment, and how markets are reacting to today’s surprising payroll data.
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
